Skip to main content
Clinical Trials/NCT01450423
NCT01450423UnknownPhase 2

Physical Exercise in Subjects With Juvenile Myoclonic Epilepsy Aged 15-50: A Randomized Controlled Trial

Lars Bo Andersen2 sites in 1 country40 target enrollmentStarted: September 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Enrollment
40
Locations
2
Primary Endpoint
Cognitive function (concentration and attention)

Study Overview

Brief Summary

Epilepsy is a chronic neurologic disorder characterized by seizures. Beside seizures people suffering from epilepsy experience several challenges related to education, work and everyday life such as learning-, problem-solving-, memory-, concentration-, attention difficulties and fatigue.

It is generally approved that physical activity (PA) has a positive effect on physical as well as mental factors. However, people with epilepsy are found to be less active and PA is rarely offered or recommended as supplement to anti-epileptic medical treatment. Few studies have investigated the effect of PA in subjects with epilepsy and additional studies of high methodical quality are needed to enable evidence-based information and counselling.

This study is carried through as a randomized controlled trial which investigates the effect of participation in a 10-week cardio exercise program in people with Juvenile Myoclonic Epilepsy aged 15-50.

The study hypothesis is that participation in a 10-week cardio exercise program will induce a positive change in cognitive function (concentration and attention) and possibly in brain-derived neurotrophic factor (BDNF). In addition it is expected that the intensity and duration of the 10-week cardio exercise program is sufficient to cause changes in physiological parameters related to a reduced risk of lifestyle diseases.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
15 Years to 50 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age: 15-50
  • •Resident: Fyen, Denmark
  • •Epileptic syndrome: Juvenile Myoclonic Epilepsy

Exclusion Criteria

  • •Physical handicaps which complicate participation in physical activity

Arms & Interventions

Physical activity

Experimental

Intervention: Physical activity (Behavioral)

Control

No Intervention

Outcomes

Primary Outcomes

Cognitive function (concentration and attention)

Time Frame: Before and after a 10-week intervention period

To assess cognitive function the following tests are used: Connor's Continuous Performance Test (CPT II), Trail Making Test part A and part B, Digit Symbol Modalities Test

physical fitness

Time Frame: Before and after a 10-week intervention period

To assess physical fitness the following test are used: Wattmax test

Secondary Outcomes

  • Brain-derived neurotrophic factor (BDNF)(Before and after a 10-week intervention period (chronic and acute))
  • Bone mineral density(Before and after a 10-week intervention period)
  • Thyroidea Stimulating Hormone (TSH)(Before and after a 10-week intervention period)
  • Insulin(Before and after a 10-week intervention period)
  • Glucose(Before and after a 10-week intervention period)
  • Lipids(Before and after a 10-week intervention period)
  • C-reactive-protein(Before and after a 10-week intervention period)
  • Seizure frequency(Before and after a 10-week intervention period)
  • Blood pressure(Before and after a 10-week intervention period)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Lars Bo Andersen

Professor

University of Southern Denmark

Study Sites (2)

Loading locations...

Similar Trials